Showing results (151-160 of 266) with videos related to

Sort By:
Pageof 27
Disease Markers|March 7, 2022
CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry StudyPietro Quaglino, Mauro Novelli, Paolo Fava, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|February 10, 2017
Recurrent herpes labialis and Herpes simplex virus-1 genitalis: what is the link?Sergio Delmonte, Francesca Sidoti, Simone Ribero, et al.
Dermatology (Basel, Switzerland)|December 9, 2025
Trend in the Diagnosis of Pyoderma Gangrenosum in Italy: A Multicenter StudyAlessandra Michelucci, Angelo Capodici, Giammarco Granieri, et al.
European Journal of Dermatology : EJD|May 20, 2017
Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective studyEmi Dika, Giulia Maria Ravaioli, Pier Alessandro Fanti, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|July 15, 2017
The large spectrum of Spitzoid tumors: a retrospective survival studyPaolo Broganelli, Simone Ribero, Ilaria Castagno, et al.
Journal of Personalized Medicine|July 27, 2024
Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life ExperienceLuca Mastorino, Paolo Dapavo, Caterina Cariti, et al.
The Journal of Dermatological Treatment|July 28, 2021
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective studyPaolo Dapavo, Niccolò Siliquini, Luca Mastorino, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|January 13, 2017
A single institute's experience on melanoma prognosis: a long-term follow-upEmi Dika, Marco A Chessa, Giulia Veronesi, et al.
Journal of Clinical Medicine|February 25, 2023
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort StudyGianluca Avallone, Carlo Alberto Maronese, Giulia Murgia, et al.
International Journal of Dermatology|July 8, 2026
Association Between pTERT Promoter Mutation Subtypes and Survival Outcomes in BRAF-Mutant Metastatic Melanoma Treated With BRAF/MEK Inhibitors: An Exploratory StudyEsperanza Manrique-Silva, Maider Aguerralde-Martin, Zaida García-Casado, et al.
Pageof 27